Paul Saladino· MD
originally in 4S if you didn't have insulin resistance evidenced by low HDL and high triglycerides there was no benefit to having a Statin even in secondary prevention
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
originally in 4S if you didn't have insulin resistance evidenced by low HDL and high triglycerides there was no benefit to having a Statin even in secondary prevention
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the event free survival was significantly lower meaning they had more negative events in lipid Triad patients these are patients with low HDL and high triglycerides